Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab (RASTS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01717859
Recruitment Status : Completed
First Posted : October 31, 2012
Last Update Posted : May 24, 2017
Genentech, Inc.
Information provided by (Responsible Party):
Dr. Veena Ranganath, University of California, Los Angeles

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2017
  Actual Study Completion Date : April 2017